ArticleJournal of diabetes investigation2018

Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.

Ryota Usui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.